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Abstract
The assessment of antigen-specific T cell responses by intracellular cytokine staining (ICS) has become a routine technique
in studies of vaccination and immunity. Here, we highlight how the duration of in vitro antigen pre-stimulation, combined
with the cytokine accumulation period, are critical parameters of these methods. The effect of varying these parameters
upon the diversity and frequency of multifunctional CD4 T cell subsets has been investigated using a murine model of TB
vaccination and in cattle naturally infected with Mycobacterium bovis. We demonstrate a substantial influence of the
duration of the antigen pre-stimulation period on the repertoire of the antigen-specific CD4 T cell responses. Increasing pre-
stimulation from 2 to 6 hours amplified the diversity of the seven potential multifunctional CD4 T cell subsets that secreted
any combination of IFN-c, IL-2 and TNF-a. However, increasing pre-stimulation from 6 to 16 hours markedly altered the
multifunctional CD4 T cell repertoire to a dominant IFN-c
+ only response. This was observed in both murine and cattle
models. Whilst these data are of particular relevance to the measurement of vaccine and infection induced immunity in
TB, more generally, they demonstrate the importance of the empirical determination of the optimum duration of the
individual culture steps of ICS assays for any model. We highlight the potential significance of variations in these
parameters, particularly when comparing data between studies and/or models including clinical trials.
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Introduction
The application of detecting antigen-specific cytokine produc-
tion in individual T cells by intracellular cytokine staining (ICS)
and flow cytometry has become a common and insightful
technique in studies of immunity to infectious diseases. The
simultaneous staining of three or more cytokines allows division of
responder cells into subsets based upon their co-production profile
and identifies cells of a ‘multifunctional/polyfunctional’ profile.
Such T cells have been strongly associated with immunity to
HIV [1,2]; influenza [3,4]; leishmania [5] and tuberculosis (TB)
[6,7,8,9,10,11,12]. Consequently, they are seen as a promising
measure of vaccine efficacy [13] and are a commonly measured
immunological parameter in clinical trials [14,15,16,17,18].
While ICS protocols have become relatively standardised
[19,20], especially in the context of minimising variability within
clinical trials [21,22,23], one variable which is often not described
is the duration of antigen pre-stimulation before a golgi transport
inhibitor is added to the culture.
The identification of these functional responses relies upon an in
vitro culture step to specifically re-stimulate the T cells with
relevant antigen. During this step, a golgi transport inhibitor such
as brefeldin A (BFA) or monensin is required to prevent secretion
and allow accumulation of intracellular proteins to levels detectible
by ICS. The choice of inhibitor is dependent on the proteins of
interest; i.e. BFA for TNF-a detection and monensin for
degranulation proteins [24].
When peptide antigens are used as the T cell stimulus the
transport inhibitor of choice can be added at the start of the
culture since they do not require endosomal processing [20].
However, when protein antigens are used, either as single
recombinant proteins or complex mixtures, then a period of pre-
stimulation is required before the addition of the transport
inhibitor to allow sufficient antigen processing before disruption
of intracellular transport mechanisms [25,26,27].
The optimal duration of this antigen pre-stimulation period
most is likely to vary between different immunity models, antigens
and culture conditions. It is therefore important that its duration
be established empirically for each model. Inevitably, the duration
of this pre-stimulation, will be a compromise between maximal
antigen presentation, adequate analyte accumulation and the
practicality of the culture schedule.
The actual effect that variations in the pre-stimulation duration
have on the cytokine responses, and ultimately the definition of
responder T cell subsets, will not be apparent until tested. Here,
we sought to examine the effect of antigen pre-stimulation
duration upon the antigen-specific CD4 T cell response in both
a murine and bovine model of TB immunity. To this aim, we
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bacille Calmette-Gue `rin (BCG) vaccination in mice as well as
those in cattle naturally infected with M. bovis. On making
comparisons between using either short (2–6 hours) or overnight
(16 hours) pre-stimulation periods, both models showed the same
substantial differences between the responder cell cytokine
repertoire detected after the different culture schedules. Our
results demonstrate the potential significance of varying the culture
duration parameters with regard to the results generated by the
ICS analyses and the interpretation the data. Given the common
use of ICS techniques, these data have important implications for
the standardisation of such assays between laboratories.
Results
The effect of different culture schedules on antigen-
specific murine CD4 T cell responses
Splenocytes were isolated from mice immunised for six weeks
with BCG and were cultured in vitro with a protein cocktail of 7
BCG derived antigens and subsequently interrogated by ICS and
flow-cytometric analysis. Five independent culture schedules were
compared in parallel. These differed by increasing lengths of
antigen pre-stimulation period (from 0 to 16 hours) and/or the
subsequent period of time after BFA addition (from 4 to 16 hours).
Multicolour ICS analysis of the simultaneous production of IFN-c,
IL-2 and TNF-a by antigen-specific CD4 T cells, allowed for the
subdivision of these cytokine producing cells into seven functional
subsets, as demonstrated on a representative sample (Figure 1A).
Samples from placebo control mice were analysed in parallel (data
not shown) and any responses were subtracted from those of the
BCG stimulations to provide vaccine specific responses.
Figure 2A shows the frequency of the CD4 T cell subsets
induced by the different culture schedules. Adding the golgi
inhibitor, BFA, at the start of antigen-stimulation induced two
dominant populations of IFN-c
+TNF-a
+ (0.13%) and triple
positive multifunctional IFN-c
+IL-2
+TNF-a
+ (0.06%) cells and
minor populations of all other subsets.
Antigen pre-stimulation for 2 hours prior to BFA addition,
increased the frequency of multifunctional IFN-c
+IL-2
+TNF-a
+
cells to 0.14%, (ns.).
Further increasing the duration of BFA treatment from 4 to
16 hours, resulted in a statistically significant reduction in IFN-
c
+TNF-a
+ cells (0.07%, p,0.01 vs. no pre-stimulation). Increasing
the duration of antigen pre-stimulation to 6 hours, revealed a
small but distinct population (0.01%) of IFN-c
+IL-2
+ cells.
Further increasing the antigen pre-stimulation period to
16 hours resulted in a significant drop from the maximal
frequency of multifunctional IFN-c
+IL-2
+TNF-a
+ cells (0.04%,
p,0.05 vs. 2+4 hours), but a concurrent significant gain in the
frequency of single IFN-c
+ cells (0.12%, p,0.001 vs. all other
conditions), IFN-c
+IL-2
+ (0.02%, p,0.05, vs. all conditions) and
IL-2
+ (0.01%; p,0.05 vs. 2+4; 2+16 and 6+16 hours) cells.
The use of peptide rather than protein antigen may require
different antigen processing mechanisms that could affect the
results. This was evaluated by running parallel analysis using an
immunodominant peptide of Rv0288, which is highly immuno-
genic in BCG immunised BALB/c mice [28,29]
Figure 2B reveals that the distribution of the profiles of peptide
induced CD4 T cell responses were less dependent on antigen pre-
stimulation to those induced by the protein cocktail. The
frequency of IFN-c
+IL-2
+TNF-a
+ cells was equivalent with no
pre-stimulation to that following 2 hours of pre-stimulation (0.17%
vs. 0.2%). Pre-stimulation with antigen did induce a reduction in
frequency of IFN-c
+TNF-a
+ cells (p,0.05 vs. 0+4 hours).
Increasing pre-stimulation to 6 hours induced significantly greater
frequencies of the rare IFN-c
+IL-2
+ cells (0.02% vs. ,0.002%,
p,0.01 vs. 0+4, 2+4o r2 +16 hours). 16 hours pre-stimulation
significantly decreased detection of multifunctional IFN-c
+IL-
2
+TNF-a
+ cells to 0.05% from their maximal frequencies (p,0.05
vs. 0+4 hours; p,0.01 vs. 2+4 hours), but significantly increased
the frequency of single IFNc
+ cells (0.1%; p,0.001 vs. all other
Figure 1. Identification of CD4
+ T cells producing IFN-c, IL-2 & TNF-a. Mouse splenocytes 6 weeks following a BCG immunization (A) and
PBMC from cattle naturally infected M. bovis (B) were isolated, stimulated with antigen, stained by intracellular cytokine staining (ICS) and
interrogated by flow cytometry. Plots were gated on live CD4
+ lymphocytes and analyzed for all combinations of simultaneous IFN-c, IL-2 and TNF-a
productivity. Numbers indicate percentage of CD4
+ cells in the seven individual cell subsets, data are representative of one of three independent
experiments.
doi:10.1371/journal.pone.0038926.g001
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+IL-2
+ (0.02%; p,0.01
vs. 0+4, 2+4o r2 +16 hours) cells were still evident.
The effect of different culture schedules on antigen-specific bovine CD4 T
cell responses.
In order to determine whether the change in multifunctional T-
cell repertoire, as influenced by the duration of antigen
stimulation, was specific to this murine model of BCG vaccination,
PBMC isolated from cattle naturally infected with M. bovis were
examined for PPD-B-specific CD4 T cell responses.
The application of ICS in the analysis of bovine cells has
recently been enhanced by the ability to additionally detect IL-2
and TNF-a [30] together with the established detection of IFN-c
[31,32]. Therefore, an equivalent parallel analysis was carried out
comparing six independent culture schedules for their affect on the
subsequent multicolour ICS analysis of the seven cytokine
producing subsets of antigen-specific CD4 T cells. The responses
from unstimulated parallel cultures were subtracted to generate
these antigen-specific responses (Figure 1B).
As shown in Figure 3A, the frequency of antigen-specific
multifunctional IFN-c
+IL-2
+TNF-a
+ cells significantly increased
with the duration of PPD-B pre-stimulation period, up to a
maximum at 6 hours: rising from 0.07% to 0.38% at 2 hours (ns.);
to 1.0% at 4 hours (p,0.05); and to 1.31% at 6 hours (p,0.001).
Extending the BFA incubation by 12 hours only increased this
response by 0.13%.
As observed in the murine system, extending the pre-stimulation
period from 6 to 16 hours, resulted in a switch to a dominant IFN-
c
+ cell response (1.23%; p,0.001 vs. all conditions), accompanied
by a significant reduction in the frequency of IFN-c
+IL-2
+TNF-a
+
(0.15%, p,0.001) and IL-2
+TNF-a
+ cells (0.2% to 0.01%,
p,0.05). This decrease in IFN-c
+IL-2
+TNF-a
+ cells also corre-
lated with a significant increase in the detection of the rare IFN-
c
+IL-2
+ subset (0.13%; p,0.05 vs. pre-stimulations ,6 hours).
As previously, parallel analyses were made using peptide
antigens. Cultures were stimulated with a peptide pool mapping
the Mycobacterium bovis immunodominant proteins ESAT-6 and
CFP-10 [33]. As seen in Figure 3B, and in contrast to protein
antigen stimulation; peptide pre-stimulation of less than 16 hours
duration failed to induce a significant increase in the frequency of
multifunctional IFN-c
+IL-2
+TNF-a
+ cells. Interestingly, the pre-
stimulation of cells with peptide for 16 hours induced equivalent
responses to those observed with protein antigen.
The effect of different culture schedules on the viability
of CD4 T cells
Another important outcome that may be influenced by the
culture schedule used is the viability of the cells post-culture. Cell
culture for ICS inherently induces a population of dead cells,
which is likely exacerbated by the toxic effect of BFA. The use of
fixable viability stains, reviewed in [34,35], allow for the exclusion
of dead cells from the analysis (seen in figure 1) to reduce non-
specific staining artefacts. Here, the affect on the viability of the
Figure 2. The effect of different culture schedules on antigen-
specific murine CD4 T cell responses. Six weeks following
immunization, spleen cells from BCG or placebo control vaccinates
were isolated, stimulated with a BCG derived recombinant protein
cocktail (A) or individual immunodominant peptide of Rv0288 (B),
stained by intracellular cytokine staining (ICS) and interrogated by flow
cytometry. Plots were gated on live CD4
+ lymphocytes and analyzed for
all combinations of simultaneous IFN-c, IL-2 and TNF-a productivity. The
stacked bar graphs represent the percentage of antigen-specific CD4
+
cells in the seven individual cell subsets, data are representative of one
of three independent experiments (n=6). Bars represent the mean 6
SEM.
doi:10.1371/journal.pone.0038926.g002
Figure 3. The effect of different culture schedules on antigen-
specific bovine CD4 T cell responses. PBMC from cattle naturally
infected with M. bovis were isolated, stimulated with PPD-B (A) or ESAT-
6/CFP-10 peptide pools (B), stained by intracellular cytokine staining
(ICS) and interrogated by flow cytometry. Plots were gated on live CD4
+
lymphocytes and analyzed for all combinations of simultaneous IFN-c,
IL-2 and TNF-a productivity. The stacked bar graphs represent the
percentage of antigen-specific CD4
+ cells in the seven individual cell
subsets, data is representative of one of three independent experiments
(n=6). Bars represent the mean 6 SEM.
doi:10.1371/journal.pone.0038926.g003
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schedules.
The frequencies of viable CD4 T cells in the murine lymphocyte
cultures did not significantly differ between stimulation schedules
(figure 4A).
In the bovine lymphocyte culture, however, stimulation
schedules involving culture for over 20 hours in total resulted in
a decline of viable CD4
+ T cells (figure 4B), irrespective of the
duration of BFA incubation. 6 hours pre-stimulation followed by
16 hours of BFA resulted in a 33% decline in viability (p,0.01 vs.
no pre-stimulation) whilst 16 hours pre-stimulation followed by
4 hours of BFA resulted in a 23% drop (ns.).
Discussion
Here, we have investigated the effect of altering the duration of
the in vitro culture parameters on the ICS analysis of the co-
production of IFN-c, IL-2 and TNF-a by antigen-specific
multifunctional CD4 T cells. Our rationale for undertaking this
investigation was to ensure the development of optimal conditions
for inducing and measuring multifunctional responses. When
developing such methodologies, the practicality of the protocol is
an important consideration especially if it is to be applied on a
routine basis. We therefore examined the length of time used for
the antigen pre-stimulation period, and that of the cytokine
accumulation period after BFA addition, in murine and bovine
CD4 T cells. Schedules that could be routinely used in the
laboratory were investigated and the biological consequences of
these schedules were assessed.
Evaluation of the cytokine response of murine and bovine
antigen-specific CD4 T cells to protein antigens demonstrated that
extending antigen pre-stimulation to 16 hours (i.e. an overnight
stimulation), followed by 4/5 hours of BFA incubation, resulted in
a response dominated by IFN-c
+ CD4 T cells. This was
accompanied by an increase in the total diversity of the response
and a reduction in the multifunctional IFN-c
+IL-2
+TNF-a
+
population, compared to the use of shorter pre-stimulation
periods.
BFA is toxic during long culture periods, presumably due to the
disruption of intracellular transport for more than a few hours.
Here, the frequency of bovine, but not murine, viable CD4 T cells
did decrease with the two longest culture periods, but this was
independent of the length of the BFA incubation. Importantly, this
decrease was not accompanied by a decline in the total antigen-
specific population.
Although the data from the murine and bovine models are
largely complimentary, one major difference in response kinetics
could be seen. The detection of bovine responder cells was clearly
augmented by the use of longer pre-stimulation periods with
protein antigen, as the frequency of IFN-c
+IL-2
+TNF-a
+ cells
increased with duration of pre-stimulation, to a maximum at
6 hours. However, in both models, this dependence on antigen
pre-stimulation for optimal multifunctional cell frequency was
abrogated when peptide antigen was used. This suggests that our
murine response may be better measured using the peptide
antigen, whilst in this bovine system there is a clear advantage in
using the protein antigen combined with pre-stimulation. This
may be due to the murine analysis being dominated by a single
clonal response to TB10.4, whilst the naturally infected cattle may
have responded to more antigens found in PPD than in the ESAT-
6/CFP-10 peptide pool.
This difference in response kinetics could be a consequence of
several factors. For example: it could be due to host differences
between mice and cattle; be due to the disparity of splenocytes
with PBMCs; or be due to differences in antigen-specific cell
populations in the two different models of immune response. One
significant factor, is that the bovine model did not use antibodies to
augment co-stimulatory activation of the T cells, such as the anti-
CD28 used in the murine analysis or anti-CD49d used addition-
ally by others. These increase the frequency of detectible antigen-
specific responding cells and depending on their degree of
utilisation, can have a substantial influence [36].
The length of pre-stimulation will affect the potential for antigen
processing/presentation, whilst the overall culture period will
increase the probability for antigen-specific antigen presenting cell
induced stimulation and activation of T cells, but explanations for
the significant effects observed here are not clear.
Effector cytokines released by antigen experienced CD4 T cells
are produced de novo [37], rather than being stored as preformed
proteins ready for immediate release. The preformed mRNA
transcripts found within these cells [38,39,40] would permit for
relatively rapid cytokine production, as illustrated by their
detection in the shorter culture periods. The increased detection
of additional functional subsets on lengthening the pre-stimulation
Figure 4. The effect of different culture schedules on the
viability of CD4 T cells. Mouse splenocytes 6 weeks following a BCG
immunization (A) and PBMC from cattle naturally infected with M. bovis
(B) were isolated, stimulated with protein cocktail or PPD-B, respec-
tively, stained by intracellular cytokine staining (ICS) and interrogated
by flow cytometry. Graphs represent the percentage of live CD4
+
lymphocytes detected in the analysis, as determined by the inclusion of
a LIVE/DEAD fixable Violet dead cell stain. Data are representative of
one of three independent experiments (n=6). Bars represent the mean
6 SEM; **p,0.01; ANOVA.
doi:10.1371/journal.pone.0038926.g004
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production of these cytokines by different populations of CD4 T
cells. These could be caused by several mechanisms. The
dynamics of production of the individual cytokines could differ,
for instance, the secretory pathway of TNF-a has been shown to
be distinct from that of IL-2 and IFN-c [41]. Alternatively, the
length of time over which these individual cytokines are produced
could differ; more sustained IFN-c than IL-2 and TNF-a
production, could explain the observed shift in the balance from
an increase in functional diversity to a predominantly IFN-c
+
response, when the pre-stimulation period was increased from 6 to
16 hours.
Nomura and colleagues compared the effect of lengthening ICS
culture pre-stimulation periods up to 20 hrs in the optimization of
detecting whole blood responses to CMV [42]. Although multi-
functionality was not assessed, the study concurred with a
substantial decrease in the detection of IL-2
+ and TNF-a
+ CD4
T cells in stimulations of 16 hours.
Previous work analysing CD40 ligand (CD154), a marker of the
antigen-specific activation of CD4 T cells, revealed that the
frequency of detectible activated cells increased until at least
6 hours of stimulation [43]. With evidence that CD154 is stored
preformed in secretory lysosomes [44], this delay in its expression
by some CD4 T cells is likely to be limited by the time needed for
an activating encounter with presented antigen. Additionally,
detection of these cells has also been shown to be influenced by the
cell density used in the culture [45].
It must be considered that such ICS analyses are a snapshot of
an in vitro initiated response and it is difficult to determine which
functional representation most accurately reflects the in vivo
situation. In the absence of such knowledge, we considered that
the detection of a combination of the greatest diversity and
frequency of functional subsets would be most prudent.
The identification of multifunctional T cells by ICS and their
associations with protective immunity [1,5] has resulted in a
multitude of studies investigating these cells. Their measurement
has become an established and central technique in many
laboratories studying immunity to infection. Therefore, our
demonstration of how sensitive this technique is to experimental
conditions is a crucial finding, with wide ranging implications.
Evaluating the quality of an immune response can be
challenging if it is unclear what constitutes a superior response,
especially when ICS analyses are not consistent and representative
between comparisons. ICS culture durations do vary between
studies, but investigators should establish exact optimal durations
for their studies as these could be dependant on specifics of the
culture, such as the T cells themselves, cell milieu composition and
the antigens used for stimulation. Where cross lab comparisons of
results are made, methodological parity is necessary, especially in
clinical trials, as discussed by Hannekom and colleagues [46].
In summary, our data have shown the substantial influence that
alterations in the duration of the ICS culture pre-stimulation
period and cytokine accumulation period can have on the cytokine
repertoire of antigen-specific CD4 T cells. Therefore, this should
be taken into account when deciding upon what protocol to use
and when interpreting and comparing ICS data between studies.
Materials and Methods
Animals
All animal procedures were approved by the Animal Health and
Veterinary Laboratories Agency (AHVLA) Animal Use Ethics
Committee (UK Home Office PCD 70/6905), and performed
under appropriate personal and project licenses within the
conditions of the Animals (Scientific Procedures) Act 1986. All
animals were housed in appropriate biological containment
facilities at the AHVLA.
Female BALB/c mice were obtained from SPF facilities at
Charles River UK Ltd. and used at 8 weeks of age. To investigate
immune responses in cattle naturally exposed to M. bovis,
tuberculin skin-test reactor cattle were recruited from UK farms
with a confirmed history of bovine TB and infection status of these
cattle was confirmed by the presence of TB lesions at post mortem
examination, as previously described [30]. Non-infected control
cattle were obtained from UK TB-free herds located in non-
endemic areas.
Mycobacteria
The vaccination strain used was the human vaccine M. bovis
BCG Danish 1331, prepared as per manufacturer’s instructions
(SSI, Denmark).
Immunization
Mice were immunized with a single intradermal (i.d.) injection
in the tail-base of 2610
5 CFU of BCG. Placebo control mice were
immunized with phosphate buffered saline (PBS). Six weeks later
mice were euthanized and spleens harvested.
Cell isolations and stimulations
Mouse spleen cells were prepared as described previously [9].
Cells were cultured at 5610
6/ml with 1 mg/ml anti-CD28 (BD
biosciences, UK) plus a pool of seven recombinant protein
antigens (Rv1886c, Rv0251, Rv0287, Rv0288, Rv3019c,
Rv3763, Rv3804c) as described previously [9], each protein at a
final concentration of 2 mg/ml. Alternatively, cells were stimulated
with the immunodominant peptide antigen (16mer: a.a.73–88) of
Rv0288 (Pepscan, the Netherlands) at a final concentration of
2 mg/ml. Samples from placebo control mice were analysed in
parallel and any responses were subtracted from those of the BCG
stimulations to provide vaccine specific responses.
Bovine peripheral blood mononuclear cells (PBMC) were
prepared as described previously [47]. Cells were cultured at
2610
6/ml in the presence of 1:100 dilution of Lelystad bovine
tuberculin purified protein derivative (PPD-B, Prionics, Switzer-
land). Alternatively, cells were stimulated with a cocktail of
peptides derived from the mycobacterial antigens ESAT-6 and
CFP-10. This peptide cocktail was prepared using 21 peptides
(16mers with 8-a.a. overlap) to provide complete mapping of the
full protein sequences of ESAT-6 and CFP-10 (Pepceuticals Ltd.,
United Kingdom). The peptide cocktail was used at a final
concentration of 5 mg/ml per peptide component. The responses
from unstimulated parallel cultures were subtracted to generate
antigen-specific responses.
Antibody staining and Flow cytometry
Murine spleen cells were pre-stimulated for 0 to 16 hours at
37uC/5% CO2 before addition of BFA (Sigma) (10 mg/ml) and
further culturing for 4 to 16 hours. Cells were washed and surface
stained with CD4–APC-H7 (BD bioscience) and LIVE/DEAD
fixable Violet dead cell stain (Invitrogen, UK). Subsequently, the
cells were washed, treated with Cytofix and Perm Wash (BD
biosciences), according to manufacturer’s instructions, to intracel-
lularly stain with IFN-c-APC (BD biosciences), IL-2–PE-Cy7 and
TNF-a-FITC (both eBioscience, USA).
Cattle PBMC were stimulated as above, washed and surface
stained with CD4-APC-AlexaFluor 750 (AbDSerotec; custom
conjugated with APC-AlexaFluor 750 by Beckman Coulter Inc.
Duration of Ag-stimulation Affects CD4 Diversity
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stain. Subsequently, the cells were washed, treated with Cytofix
and Perm Wash and intracellularly stained with IFN-c-PE, TNF-
a-AlexaFluor 488 and IL-2-DyLight649 (all AbD Serotec) [30].
Cells were analysed using a CyAn ADP analyser and Summit
software (Beckman Coulter, USA), on acquisitions of a minimum
of 100,000 live lymphocytes.
Statistical analyses
All data were analyzed using the Graphpad Instat 3 statistical
package (Graphpad, USA). Data were analyzed by ANOVA with
Tukey-Kramer (ICS) or Dunnett post test (viability).
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